UFR Faculté de Médecin Lyon-Sud-Charles Mérieux BP12 165 Chemin du Grand Revoyet 69921 OULLINS Cedex
33 (0)4 26 23 59 03
33 (0)4 26 23 59 01
Target treatments for cancer by way of surgery combined with chemical hyperthermia, using physical agents (conformal radiotherapy, isotopes and brachytherapy), and chemotherapy (pharmacokinetics and population models).
Team 1 run by Olivier Glehen: animal models and peritoneal carcinosis, evaluation of targeted intraperitoneal therapy on animal models, and phase II clinical trials (National centre of excellence)
Team 2 run by Gilles Freyer: evaluation of the pharmacokinetics of anti-cancer drugs and the impact of pharmacokinetics on anti-tumoral efficacy, construction of population models, phase I and phase II clinical trials.
Team 3 run by Olivier Chapet: evaluation of conformal radiotherapy, the use of 3D imaging in increasing the precision of ballistic targeting, phase III clinical trials.
Team 4 run by Claire Rodriguez Lafrasse: radiobiology and the study of molecular resistance of cancer cells to irradiation (X rays, electrons, carbon ions)